Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Long-acting nitrate compounds (author's transl)].

F Lhoste

    La Nouvelle Presse Medicale
    |September 25, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Long-acting nitrate compounds show clinical effectiveness for chronic coronary disease and heart failure. Further research is needed to standardize comparisons due to varied study methods and isolated reports.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [8th Descartes-Berkeley interuniversity symposium on health economics, May 2013, Paris, France: an overview].

    Annales pharmaceutiques francaises·2013
    Same author

    [Trust-based economics with medicine outcome-based pricing].

    Annales pharmaceutiques francaises·2013
    Same author

    Is uranyl scavenger hexakis(3,6-anhydro) tetrakis(2A,B,D,E-O-octyl) cyclomaltohexaose (OCT) relevant with biosystems?

    Bollettino chimico farmaceutico·2001
    Same author

    1H-NMR study of heavy metals complexation with hexakis(3,6-anhydro) tetrakis(2A,B,D,E-O-octyl) cyclomaltohexaose (OCT).

    Bollettino chimico farmaceutico·2001
    Same author

    [Postoperative analgesia after ligamentoplasty of the knee. Comparison of epidural morphine and intravenous nalbuphine].

    Cahiers d'anesthesiologie·1995
    Same author

    Head injury: clonidine decreases plasma catecholamines.

    Critical care medicine·1990
    Same journal

    [Forms of intra-erythrocytes asexual multiplication of P. falciparium. Production of monoclonal antibodies].

    La Nouvelle presse medicale·2016
    Same journal

    [Cutaneous systemic angiitis in hairy cell leukemia].

    La Nouvelle presse medicale·1982
    Same journal

    [Isolated late epilepsy as manifestation of glioblastoma. True negative tests with the scanner].

    La Nouvelle presse medicale·1982
    Same journal

    [Non-specific benign ulcer of the colon. Arguments favoring its ischemic origin].

    La Nouvelle presse medicale·1982
    Same journal

    [Relation between psychological stress and obstetrical complications. Preliminary data].

    La Nouvelle presse medicale·1982
    Same journal

    [Significance of a "flat" curve of oral hyperglycemia. Comparison with a test meal].

    La Nouvelle presse medicale·1982
    See all related articles

    Area of Science:

    • Cardiovascular pharmacology
    • Pharmacotherapy
    • Nitrate drug development

    Context:

    • Nitrate compounds, initially for angina pectoris, are now explored for chronic coronary disease and heart failure.
    • Sustained therapeutic activity is crucial for these new indications, driving the development of slowly metabolized derivatives and modified preparations.

    Purpose:

    • To evaluate the clinical effectiveness of long-acting nitrate compounds in treating chronic cardiovascular conditions.
    • To explore novel pharmaceutical preparations and derivatives for sustained nitrate therapy.

    Summary:

    • Recent data indicate that long-acting nitrate compounds are clinically effective for chronic coronary disease and congestive heart failure.
    • Development focuses on slowly metabolized derivatives and modified pharmaceutical preparations to ensure sustained therapeutic activity.

    Related Experiment Videos

  • Comparisons across studies are challenging due to diverse methodologies, dosage regimens, and reliance on isolated case reports.

    • Impact:

    • Highlights the potential of long-acting nitrates in expanding cardiovascular treatment options.
    • Underscores the need for standardized research protocols to facilitate robust clinical comparisons.
    • Suggests a growing role for modified nitrate formulations in managing chronic heart conditions.